J. THORNTON to United States
This is a "connection" page, showing publications J. THORNTON has written about United States.
Connection Strength
0.466
-
Characterising incident opioid use among incident users of prescription sedative hypnotics: A national cohort study. BMJ Open. 2024 May 30; 14(5):e082339.
Score: 0.069
-
Patients' willingness to pay for naloxone: A national cross-sectional survey of prescription opioid users with chronic pain in the United States. J Am Pharm Assoc (2003). 2024 May-Jun; 64(3):102062.
Score: 0.067
-
Productivity Loss Among Opioid and Benzodiazepine Users in the United States: A Medical Expenditure Panel Survey From 2010 to 2019. J Occup Environ Med. 2024 Mar 01; 66(3):226-233.
Score: 0.066
-
Physician perspective on the implementation of risk mitigation strategies when prescribing opioid medications: a qualitative analysis. BMC Health Serv Res. 2023 Oct 31; 23(1):1185.
Score: 0.066
-
Parents' intention to have their child vaccinated at a community pharmacy: A national cross-sectional survey. J Am Pharm Assoc (2003). 2023 Mar-Apr; 63(2):511-517.e8.
Score: 0.061
-
Comparing Two Databases to Identify Access to Buprenorphine Treatment for Opioid Use Disorder. J Pain Palliat Care Pharmacother. 2022 Jun; 36(2):103-111.
Score: 0.060
-
Marginal health care expenditures for melanoma care in the United States. J Manag Care Spec Pharm. 2024 Dec; 30(12):1364-1374.
Score: 0.018
-
Opioid and Non-Opioid Pharmacotherapy Use for Pain Management Among Privately Insured Pediatric Patients With Cancer in the United States. Oncologist. 2024 Feb 02; 29(2):176-184.
Score: 0.017
-
Management of metastatic melanoma in Texas: disparities in the utilization of immunotherapy following the regulatory approval of immune checkpoint inhibitors. BMC Cancer. 2023 Jul 13; 23(1):655.
Score: 0.016
-
Factors Associated with Prescribing Oral Disease Modifying Agents in Multiple Sclerosis: a Real-world Analysis of Electronic Medical Records. Mult Scler Relat Disord. 2020 Oct; 45:102334.
Score: 0.013
-
Marginal Health Care Expenditure Burden Among U.S. Civilian Noninstitutionalized Individuals with Multiple Sclerosis: 2010-2015. J Manag Care Spec Pharm. 2020 Jun; 26(6):741-749.
Score: 0.013